Medical Research
(H19)
990 on File
ZEBRAFISH DISEASE MODELS SOCIETY
Financial strength (30%)
94/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$212K
Total Revenue
$197K
Total Expenses
$253K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
81.6%
Fundraising Efficiency
N/A
Operating Reserve
15.43x
Liability-to-Asset
8.3%
Revenue Diversification
91.9%
Compared with Peers
FY 2025
Compared with 370 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
81.6% | 83.6% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
18.2% | 10.6% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.2% | 0.0% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
15.4 mo | 12.3 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
8.3% | 0.1% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.9% | 91.9% |
P10P90
|
Below median |
|
Surplus margin
Surplus as a share of revenue
|
7.3% | -1.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $212K | $197K | $253K | 81.6% | 0 |
| 2023 | $194K | $239K | $189K | 86.5% | 0 |
| 2022 | $214K | $248K | $234K | 83.0% | 0 |
| 2021 | $148K | $107K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.